one23

REGN: Returned to IBD Leaders today

Long
NASDAQ:REGN   Regeneron Pharmaceuticals, Inc.
0
Nice clean gap
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.